DK1021541T3 - Aminoterminalt trunkeret MCP-2 som chemokinantagonister - Google Patents

Aminoterminalt trunkeret MCP-2 som chemokinantagonister

Info

Publication number
DK1021541T3
DK1021541T3 DK98947553T DK98947553T DK1021541T3 DK 1021541 T3 DK1021541 T3 DK 1021541T3 DK 98947553 T DK98947553 T DK 98947553T DK 98947553 T DK98947553 T DK 98947553T DK 1021541 T3 DK1021541 T3 DK 1021541T3
Authority
DK
Denmark
Prior art keywords
chemokine antagonists
truncated mcp
aminoterminally
aminoterminally truncated
mcp
Prior art date
Application number
DK98947553T
Other languages
Danish (da)
English (en)
Inventor
Paul Proost
Sofie Struyf
Damme Jo Van
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1021541(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1021541T3 publication Critical patent/DK1021541T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK98947553T 1997-09-29 1998-09-28 Aminoterminalt trunkeret MCP-2 som chemokinantagonister DK1021541T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97116863A EP0906954A1 (en) 1997-09-29 1997-09-29 Amino-terminal truncated c-c chemokines as chemokine antagonist
EP97122471A EP0905240A1 (en) 1997-09-29 1997-12-19 Amino-terminally truncated c-c chemokines as chemokine antagonists
EP98104216A EP0905241A1 (en) 1997-09-29 1998-03-10 Amino-terminally truncated c-c chemokines as chemokine antagonists

Publications (1)

Publication Number Publication Date
DK1021541T3 true DK1021541T3 (da) 2004-08-02

Family

ID=8227408

Family Applications (3)

Application Number Title Priority Date Filing Date
DK98947553T DK1021541T3 (da) 1997-09-29 1998-09-28 Aminoterminalt trunkeret MCP-2 som chemokinantagonister
DK98951476T DK1019507T3 (da) 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister
DK04007579T DK1439231T3 (da) 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK98951476T DK1019507T3 (da) 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister
DK04007579T DK1439231T3 (da) 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister

Country Status (29)

Country Link
US (5) US6977071B2 (sk)
EP (6) EP0906954A1 (sk)
JP (2) JP4233214B2 (sk)
KR (2) KR100542934B1 (sk)
CN (3) CN1233415C (sk)
AR (2) AR013528A1 (sk)
AT (3) ATE263242T1 (sk)
AU (2) AU750341B2 (sk)
BG (2) BG64679B1 (sk)
BR (2) BR9812565A (sk)
CA (2) CA2305017A1 (sk)
CY (1) CY1110927T1 (sk)
CZ (2) CZ299479B6 (sk)
DE (3) DE69822856T2 (sk)
DK (3) DK1021541T3 (sk)
EA (2) EA003942B1 (sk)
EE (2) EE200000152A (sk)
ES (3) ES2287601T3 (sk)
HK (3) HK1062637A1 (sk)
HU (2) HU226414B1 (sk)
IL (2) IL135351A (sk)
NO (2) NO20001584D0 (sk)
NZ (3) NZ516027A (sk)
PL (2) PL196427B1 (sk)
PT (3) PT1439231E (sk)
SK (2) SK286439B6 (sk)
UA (2) UA73081C2 (sk)
WO (2) WO1999016877A1 (sk)
ZA (2) ZA988676B (sk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6534626B1 (en) * 1997-12-01 2003-03-18 The United States Of America As Represented By The Department Of Health & Human Services Chemokine variants
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
DE60030749T2 (de) * 1999-10-25 2007-09-20 Pharis Biotec Gmbh Prozessiertes menschliches chemokin phc-1
EP1167527A1 (en) * 2000-06-22 2002-01-02 Euroscreen S.A. Processed human chemokines PHC-1 and PHC-2
AU2505601A (en) * 1999-11-15 2001-05-30 Wolf-Georg Forssmann Novel use of hcc-2
CA2316405A1 (en) * 2000-05-26 2001-11-26 Ian Clark-Lewis Modulation of inflammation by protease products
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
GB2373785A (en) * 2001-03-28 2002-10-02 Rega Inst For Medical Res Truncating chemokines using dipeptidyl peptidase IV
US7553483B2 (en) 2001-12-17 2009-06-30 Merck Serono Sa Chemokine mutants acting as chemokine antagonists
WO2004104216A2 (en) * 2003-05-21 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
DE102005049637A1 (de) * 2005-10-14 2007-04-26 Rheinisch-Westfälische Technische Hochschule Aachen Antagonisten gegen die Interaktion von PF4 und RANTES
DK2185719T3 (en) 2007-08-02 2014-02-17 Novimmune Sa ANTI-RANTES ANTIBODIES AND PROCEDURES FOR USE THEREOF
WO2011097567A1 (en) * 2010-02-08 2011-08-11 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Rantes multiplexed assay, rantes variants related to disease, and rantes variants related to enzymatice activity
US9296803B2 (en) 2010-03-11 2016-03-29 Health Research, Inc. Methods and compositions containing Fc fusion proteins for enhancing immune responses
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途
EP3813869B1 (en) 2018-05-28 2023-10-18 Université de Genève Ccr5 inhibitor for use in treating a neuroinflammatory disorder that involves cerebral inflammation
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US11402391B2 (en) 2020-12-21 2022-08-02 Incelldx, Inc. Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01265099A (ja) 1987-10-08 1989-10-23 Stichting Rega Vzw 抗ｈｉｖ活性をもつ３’，−フルオロプリン−２’，３’−ジデオキシリボシド類
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
WO1996017935A2 (en) * 1994-12-08 1996-06-13 Glaxo Group Limited Rantes peptide and fragments and compositions comprising it for treatment of inflammation
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
WO1997035982A2 (en) * 1996-03-27 1997-10-02 Icos Corporation Monocyte chemotactic protein-5 materials and methods
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
US6168784B1 (en) * 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use

Also Published As

Publication number Publication date
AR013528A1 (es) 2000-12-27
NZ516027A (en) 2003-05-30
AU750606B2 (en) 2002-07-25
CN1148447C (zh) 2004-05-05
DK1439231T3 (da) 2007-11-05
US20050201977A1 (en) 2005-09-15
JP4233214B2 (ja) 2009-03-04
PT1019507E (pt) 2004-06-30
KR20010024213A (ko) 2001-03-26
HUP0003563A3 (en) 2005-11-28
NZ503235A (en) 2002-08-28
EP1439231A3 (en) 2004-12-22
ES2218860T3 (es) 2004-11-16
HK1032425A1 (en) 2001-07-20
KR20010024214A (ko) 2001-03-26
DE69823218T2 (de) 2004-08-26
US20050164936A1 (en) 2005-07-28
KR100560275B1 (ko) 2006-03-10
ATE263242T1 (de) 2004-04-15
CN1271385A (zh) 2000-10-25
HU226414B1 (en) 2008-11-28
IL135351A (en) 2006-08-20
CN1145693C (zh) 2004-04-14
EP1021541B1 (en) 2004-04-14
CN1490049A (zh) 2004-04-21
DE69838188D1 (de) 2007-09-13
JP4230659B2 (ja) 2009-02-25
US6905676B2 (en) 2005-06-14
PL197569B1 (pl) 2008-04-30
EA003942B1 (ru) 2003-10-30
DK1019507T3 (da) 2004-07-19
AU750341B2 (en) 2002-07-18
SK286495B6 (sk) 2008-11-06
ZA988676B (en) 1999-12-03
HUP0003505A3 (en) 2005-11-28
KR100542934B1 (ko) 2006-01-11
PT1439231E (pt) 2007-08-20
SK286439B6 (sk) 2008-10-07
CA2305017A1 (en) 1999-04-08
EE200000151A (et) 2001-02-15
HK1062637A1 (en) 2004-11-19
CZ20001146A3 (cs) 2000-09-13
AU9442098A (en) 1999-04-23
SK4502000A3 (en) 2000-09-12
BG104267A (en) 2000-11-30
NZ503234A (en) 2002-06-28
EP1439231A2 (en) 2004-07-21
CZ20001147A3 (cs) 2000-09-13
ZA988675B (en) 1999-11-24
US6977071B2 (en) 2005-12-20
PT1021541E (pt) 2004-07-30
CN1233415C (zh) 2005-12-28
HU226468B1 (en) 2008-12-29
US7326411B2 (en) 2008-02-05
PL339545A1 (en) 2000-12-18
NO20001584L (no) 2000-03-27
EP1019507A1 (en) 2000-07-19
EP1439231B1 (en) 2007-08-01
DE69822856T2 (de) 2004-08-19
UA73080C2 (en) 2005-06-15
EP1021541A1 (en) 2000-07-26
WO1999016877A1 (en) 1999-04-08
EP1019507B1 (en) 2004-03-31
AR013529A1 (es) 2000-12-27
EP0906954A1 (en) 1999-04-07
DE69838188T2 (de) 2007-11-22
BR9812394A (pt) 2000-09-12
IL135352A (en) 2006-08-20
HK1032426A1 (en) 2001-07-20
PL196427B1 (pl) 2008-01-31
UA73081C2 (en) 2005-06-15
NO20001609D0 (no) 2000-03-28
ATE368742T1 (de) 2007-08-15
HUP0003505A2 (hu) 2001-02-28
US20030124677A1 (en) 2003-07-03
SK4512000A3 (en) 2000-09-12
CA2304827A1 (en) 1999-04-08
CN1271386A (zh) 2000-10-25
EA200000378A1 (ru) 2000-10-30
CZ299479B6 (cs) 2008-08-06
NO20001609L (no) 2000-03-28
JP2001518296A (ja) 2001-10-16
US20050220790A1 (en) 2005-10-06
BG64679B1 (bg) 2005-11-30
CY1110927T1 (el) 2015-06-10
JP2001518297A (ja) 2001-10-16
WO1999016876A1 (en) 1999-04-08
EA200000379A1 (ru) 2000-10-30
BR9812565A (pt) 2000-08-01
ES2215324T3 (es) 2004-10-01
ATE264390T1 (de) 2004-04-15
US20030119148A1 (en) 2003-06-26
EE200000152A (et) 2001-02-15
BG104266A (en) 2000-11-30
ES2287601T3 (es) 2007-12-16
PL339559A1 (en) 2000-12-18
BG64757B1 (bg) 2006-02-28
CZ299478B6 (cs) 2008-08-06
HUP0003563A2 (hu) 2001-02-28
EP0905241A1 (en) 1999-03-31
EP0905240A1 (en) 1999-03-31
US7338653B2 (en) 2008-03-04
DE69823218D1 (de) 2004-05-19
NO20001584D0 (no) 2000-03-27
DE69822856D1 (de) 2004-05-06
EA003940B1 (ru) 2003-10-30
AU9747498A (en) 1999-04-23

Similar Documents

Publication Publication Date Title
DK1021541T3 (da) Aminoterminalt trunkeret MCP-2 som chemokinantagonister
DE69719354D1 (de) Muscarin-antagonisten
FI971685A (fi) Takykiniini-antagonisteja
DE69812096T2 (de) Neuropeptid y rezeptorantagonisten
PT921242E (pt) Estrutura acustica de edificios
ATE266025T1 (de) Thrombin-rezeptor antagonisten
DK0871623T3 (da) 3-Azetinidylalkylpiperidiner eller -pyrrolidiner som tachykininantagonister
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
ITRM970524A3 (it) Il toglisinghiozzo
DE59806726D1 (de) T-butylperoxy-cyclododecyl-oxalat
DK0964867T3 (da) Tachykininantagonister
IL135352A0 (en) Truncated mcp-2 as chemokine antagonist
FI3380U1 (fi) Suojakatos
UA25677A (uk) Горілка
IT242690Y1 (it) Tappo di sughero
KR980004088U (ko) 보일러의 상판구조
IT243110Y1 (it) Struttura di tavolo
FI3265U1 (fi) Liitäntäkeskus
ATA44797A (de) Versteifungskonstruktion
FI974059A (fi) Hirsielementti
ITVI970132A0 (it) Elevatore autocarrato